The Cisplatin-resistant HNSCC cells showed a dose-dependent increase in the ALDHhighCD44high CSC fraction (Fig. 5A) as compared to the parent cell lines, likewise activation of STAT3 signaling and expression of Bmi-1 (Fig. 5B). The gene discussed is STAT3; the disease is head and neck squamous cell carcinoma.